JP2022509763A5 - - Google Patents
Info
- Publication number
- JP2022509763A5 JP2022509763A5 JP2021525159A JP2021525159A JP2022509763A5 JP 2022509763 A5 JP2022509763 A5 JP 2022509763A5 JP 2021525159 A JP2021525159 A JP 2021525159A JP 2021525159 A JP2021525159 A JP 2021525159A JP 2022509763 A5 JP2022509763 A5 JP 2022509763A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- pharmaceutically acceptable
- independently selected
- compound according
- alkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862776390P | 2018-12-06 | 2018-12-06 | |
| US62/776,390 | 2018-12-06 | ||
| PCT/US2019/064223 WO2020117794A1 (en) | 2018-12-06 | 2019-12-03 | Compounds for the treatment of arenavirus infection |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022509763A JP2022509763A (ja) | 2022-01-24 |
| JP2022509763A5 true JP2022509763A5 (cg-RX-API-DMAC7.html) | 2022-12-07 |
| JP7675009B2 JP7675009B2 (ja) | 2025-05-12 |
Family
ID=70975517
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021525159A Active JP7675009B2 (ja) | 2018-12-06 | 2019-12-03 | アレナウイルス感染症の治療のための化合物 |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP3890731A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP7675009B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR20210106997A (cg-RX-API-DMAC7.html) |
| CN (1) | CN113329750B (cg-RX-API-DMAC7.html) |
| AR (1) | AR117228A1 (cg-RX-API-DMAC7.html) |
| AU (1) | AU2019393784B2 (cg-RX-API-DMAC7.html) |
| BR (1) | BR112021010909A2 (cg-RX-API-DMAC7.html) |
| EA (1) | EA202191001A1 (cg-RX-API-DMAC7.html) |
| MX (2) | MX2021005234A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2020117794A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN116217490B (zh) * | 2023-02-03 | 2025-09-26 | 中国人民解放军军事科学院军事医学研究院 | 一种苯并咪唑类化合物及其制备方法和应用 |
| EP4434972A1 (en) * | 2023-03-22 | 2024-09-25 | Eberhard-Karls-Universität Tübingen | Atm kinase inhibitors |
| WO2025137345A1 (en) * | 2023-12-20 | 2025-06-26 | Arisan Therapeutics Inc. | Crystalline forms of an imidazopyridine derivative |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2293638T3 (es) * | 1994-03-25 | 2008-03-16 | Isotechnika, Inc. | Mejora de la eficacia de farmacos por deuteracion. |
| WO2012065297A1 (en) * | 2010-11-16 | 2012-05-24 | Impact Therapeutics, Inc. | 3-ARYL-6-ARYL-[1,2,4]TRIAZOLO[4,3-a]PYRIDINES AS INHIBITORS OF CELL PROLIFERATION AND THE USE THEREOF |
| AP3675A (en) * | 2012-02-17 | 2016-04-15 | Kineta Four Llc | Antiviral drugs for treatment of arenavirus infection |
| US9688680B2 (en) | 2014-08-04 | 2017-06-27 | Blueprint Medicines Corporation | Compositions useful for treating disorders related to kit |
| US11352328B2 (en) | 2016-07-12 | 2022-06-07 | Arisan Therapeutics Inc. | Heterocyclic compounds for the treatment of arenavirus |
-
2019
- 2019-12-02 AR ARP190103517A patent/AR117228A1/es unknown
- 2019-12-03 MX MX2021005234A patent/MX2021005234A/es unknown
- 2019-12-03 CN CN201980080594.2A patent/CN113329750B/zh active Active
- 2019-12-03 EA EA202191001A patent/EA202191001A1/ru unknown
- 2019-12-03 EP EP19892030.8A patent/EP3890731A4/en active Pending
- 2019-12-03 WO PCT/US2019/064223 patent/WO2020117794A1/en not_active Ceased
- 2019-12-03 AU AU2019393784A patent/AU2019393784B2/en active Active
- 2019-12-03 JP JP2021525159A patent/JP7675009B2/ja active Active
- 2019-12-03 BR BR112021010909-9A patent/BR112021010909A2/pt unknown
- 2019-12-03 KR KR1020217017726A patent/KR20210106997A/ko not_active Ceased
-
2021
- 2021-05-04 MX MX2024013042A patent/MX2024013042A/es unknown